Free Trial
→ Think NVDA’s run was epic? You ain’t seen nothin’ yet (From Timothy Sykes) (Ad) Buy NLSPW Stock  Free NLSPW Stock Alerts

NLS Pharmaceutics (NLSPW) SEC Filings & 10K Form

NLS Pharmaceutics logo
$0.01 +0.00 (+7.69%)
As of 03:44 PM Eastern
Compare

Recent NLS Pharmaceutics SEC Filings

Export to Excel
DateFilerForm TypeView
05/01/2025
8:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form NT 20-F
04/15/2025
8:05 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/15/2025
8:07 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
04/14/2025
3:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form D
Notice of Exempt Offering of Securities 
03/31/2025
4:23 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-4/A
03/31/2025
9:24 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
03/31/2025
8:29 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
8:20 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
8:21 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
03/03/2025
5:40 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-4/A
02/27/2025
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/25/2025
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/25/2025
7:02 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
02/14/2025
4:08 PM		Lind Global Fund II LP (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form SCHEDULE 13G/A
02/10/2025
4:43 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
02/10/2025
6:57 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
02/10/2025
6:54 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/05/2025
5:45 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
01/31/2025
6:47 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2025
6:51 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
01/30/2025
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/28/2025
9:46 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
01/28/2025
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/22/2025
4:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form D
Notice of Exempt Offering of Securities 
01/16/2025
8:20 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/16/2025
8:22 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
01/14/2025
3:27 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2025
7:04 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2025
7:14 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
01/07/2025
3:30 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/30/2024
7:52 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/30/2024
7:54 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
12/30/2024
5:13 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-4
Registration statement for securities of certain foreign private issuers issued in certain business combination transactions  
12/23/2024
3:04 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/19/2024
3:23 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K/A
12/19/2024
7:30 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/19/2024
7:32 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
12/17/2024
3:30 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2024
7:30 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2024
7:32 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
12/10/2024
7:30 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K/A
Elon just did WHAT!? (Ad)

As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.

Click here to see how to claim your stake before they launch to avoid missing out.
12/03/2024
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/26/2024
11:15 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form EFFECT
11/21/2024
3:01 PM		Hafner Ronald (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form SC 13G/A
11/18/2024
7:30 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/15/2024
4:00 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
6:27 PM		Lind Global Fund II LP (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form SC 13G/A
11/08/2024
3:00 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/05/2024
3:30 PM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
11/05/2024
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2024
6:39 PM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
YA II PN, Ltd. (Filed by)
Form SC 13G/A
11/04/2024
5:20 PM		Grisard Felix (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form SC 13G/A
11/04/2024
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2024
7:02 AM		NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form 425
10/28/2024
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/23/2024
3:00 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
10/22/2024
3:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/21/2024
4:19 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form D
Notice of Exempt Offering of Securities 
10/18/2024
3:31 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
12:24 PM		ALPHA CAPITAL ANSTALT (Filed by)
NLS Pharmaceutics Ltd. (Subject)
NLS Pharmaceutics (Subject)
Form SC 13G
10/15/2024
8:09 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2024
7:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2024
6:00 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/01/2024
3:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/25/2024
7:13 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/19/2024
3:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/13/2024
4:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/27/2024
3:01 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
08/26/2024
3:40 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/30/2024
3:30 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/15/2024
8:16 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form D
Notice of Exempt Offering of Securities 
07/01/2024
7:26 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 424B5
07/01/2024
7:09 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/27/2024
3:54 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/25/2024
11:15 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form EFFECT
06/25/2024
3:31 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/25/2024
8:28 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2024
8:13 AM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/24/2024
4:25 PM		NLS Pharmaceutics Ltd. (Filer)
NLS Pharmaceutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:NLSPW) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...
Golden Portfolio | Sponsored
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsored
Is President Trump Lying To You With This?
President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...
Colonial Metals | Sponsored
July 2025 Rule Change to Impact Retirement Investors
There's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...
Premier Gold Co | Sponsored
Silver Is the New Oil—And the World’s Running Dry
Elon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...
Priority Gold | Sponsored
Trump’s Bitcoin Reserve is No Accident…
Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...
Crypto 101 Media | Sponsored